Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib

Saved in:
Bibliographic Details
Main Authors: Valentina Natoli, Serena Palmeri, Ana Isabel Rebollo-Giménez, Caterina Matucci-Cerinic, Paola Bocca, Roberta Caorsi, Stefano Volpi, Riccardo Papa, Alessandro Consolaro, Marco Gattorno, Angelo Ravelli, Silvia Rosina
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Online Access:https://doi.org/10.1186/s12969-024-01044-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850237998914863104
author Valentina Natoli
Serena Palmeri
Ana Isabel Rebollo-Giménez
Caterina Matucci-Cerinic
Paola Bocca
Roberta Caorsi
Stefano Volpi
Riccardo Papa
Alessandro Consolaro
Marco Gattorno
Angelo Ravelli
Silvia Rosina
author_facet Valentina Natoli
Serena Palmeri
Ana Isabel Rebollo-Giménez
Caterina Matucci-Cerinic
Paola Bocca
Roberta Caorsi
Stefano Volpi
Riccardo Papa
Alessandro Consolaro
Marco Gattorno
Angelo Ravelli
Silvia Rosina
author_sort Valentina Natoli
collection DOAJ
format Article
id doaj-art-bc8f7efeb0824486b629760a9b5da21f
institution OA Journals
issn 1546-0096
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Pediatric Rheumatology Online Journal
spelling doaj-art-bc8f7efeb0824486b629760a9b5da21f2025-08-20T02:01:35ZengBMCPediatric Rheumatology Online Journal1546-00962025-02-012311510.1186/s12969-024-01044-5Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinibValentina Natoli0Serena Palmeri1Ana Isabel Rebollo-Giménez2Caterina Matucci-Cerinic3Paola Bocca4Roberta Caorsi5Stefano Volpi6Riccardo Papa7Alessandro Consolaro8Marco Gattorno9Angelo Ravelli10Silvia Rosina11Università degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI)Università degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI)Università degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI)Università degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI)IRCCS Istituto Giannina Gaslini, Paediatric Rheumatology and Autoinflammatory Diseases UnitIRCCS Istituto Giannina Gaslini, Paediatric Rheumatology and Autoinflammatory Diseases UnitUniversità degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI)IRCCS Istituto Giannina Gaslini, Paediatric Rheumatology and Autoinflammatory Diseases UnitUniversità degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI)IRCCS Istituto Giannina Gaslini, Paediatric Rheumatology and Autoinflammatory Diseases UnitUniversità degli Studi di Genova, Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DiNOGMI)IRCCS Istituto Giannina Gaslini, Paediatric Rheumatology and Autoinflammatory Diseases Unithttps://doi.org/10.1186/s12969-024-01044-5Juvenile dermatomyositisAnti-MDA5 antibodiesInterstitial lung diseaseTofacitinibJAK inhibitorsType I IFN gene signature
spellingShingle Valentina Natoli
Serena Palmeri
Ana Isabel Rebollo-Giménez
Caterina Matucci-Cerinic
Paola Bocca
Roberta Caorsi
Stefano Volpi
Riccardo Papa
Alessandro Consolaro
Marco Gattorno
Angelo Ravelli
Silvia Rosina
Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
Pediatric Rheumatology Online Journal
Juvenile dermatomyositis
Anti-MDA5 antibodies
Interstitial lung disease
Tofacitinib
JAK inhibitors
Type I IFN gene signature
title Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
title_full Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
title_fullStr Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
title_full_unstemmed Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
title_short Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
title_sort successful treatment of an anti mda5 antibody positive juvenile dermatomyositis patient with refractory interstitial lung disease using tofacitinib
topic Juvenile dermatomyositis
Anti-MDA5 antibodies
Interstitial lung disease
Tofacitinib
JAK inhibitors
Type I IFN gene signature
url https://doi.org/10.1186/s12969-024-01044-5
work_keys_str_mv AT valentinanatoli successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT serenapalmeri successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT anaisabelrebollogimenez successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT caterinamatuccicerinic successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT paolabocca successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT robertacaorsi successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT stefanovolpi successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT riccardopapa successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT alessandroconsolaro successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT marcogattorno successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT angeloravelli successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib
AT silviarosina successfultreatmentofanantimda5antibodypositivejuveniledermatomyositispatientwithrefractoryinterstitiallungdiseaseusingtofacitinib